The introduction of glucagon-like peptide-1 (GLP-1) receptor agonists, equivalent to semaglutide (Ozempic and Wegovy) is a breakthrough within the administration of weight problems. These drugs have confirmed to be very efficient in selling weight reduction and bettering blood sugar ranges.
Whereas lots of people might imagine that I’ve one thing towards GLP-1s – whether or not as a result of they’re ‘competitors’ for my apply (they aren’t), or that perhaps I don’t agree with utilizing prescription drugs over weight loss program for weight reduction. I wrote all about that right here.
I consider the brand new class of weight reduction drugs are unbelievable instruments that can assist to vary individuals’s lives for the higher. However they aren’t all the puzzle; they’re solely only a piece, and there are some very actual limitations to their use.
Current analysis suggests that weight problems charges within the US have dropped very barely – from 46% in 2022 to 45.6% in 2023. There was a 700% improve in using GLP-1 agonist drugs between 2019 and 2023.
Though even a 0.04% change in weight problems charges could point out a basic downward pattern that could be attributed partly to GLP-1 drugs, there are good causes to consider that these medication won’t drastically cut back the prevalence of weight problems…no less than, not now. However why?
The reply to this query is multifaceted and sophisticated.
Limitations of GLP-1 Medicines in Addressing Inhabitants-Broad Epidemic
Value and Accessibility: These drugs are tremendous costly – as in, over $15,000 a yr in some circumstances. This can be a big barrier for individuals who can’t afford to pay out of pocket, or who don’t have personal insurance coverage protection. Even for these with personal insurance coverage, corporations usually cap spending or period for GLP-1 drugs. Whereas some individuals qualify for GLP-1 meds via Medicare or Medicaid, many don’t.
A current listening to of the US Senate Committee on Well being, Training, Labor, and Pensions revealed that Ozempic prices 15x extra in america than in Germany. Information on affected person discontinuation of GLP-1 receptor agonist drugs is inconclusive, however numbers vary from round 50% inside 3 months to 75% by the two yr mark. The explanations for going off the meds embody price, unwanted effects, or gradual weight reduction.
In different phrases, so many individuals who would possible profit drastically from these drugs, simply can’t entry them in any respect, or for lengthy sufficient. Entry is decrease for individuals in sure racial and ethnic teams, that are additionally the teams which have the very best charges of weight problems (and the bottom entry to healthcare general).
The patents for a number of of those drugs are up in March, 2026, that means that inexpensive generic variations of semaglutide will possible be available on the market shortly after that. Will they be rather more reasonably priced? Solely time will inform.
Sustainability of Results: Whereas GLP-1 drugs are efficient for weight reduction, analysis means that these drugs are in all probability a long-term dedication. For many individuals, their advantages are contingent on continued use. A research from the STEP 1 trial highlighted that two-thirds of the load misplaced utilizing semaglutide was regained inside a yr after remedy discontinuation. Because the numbers point out, some weight regain is probably going, however that’s not essentially true for everybody.
After I work with purchasers who’re on GLP-1 agonist drugs, we focus not solely on meals, but additionally on relationship with meals and with way of life adjustments equivalent to rising bodily exercise.
Limitations on Efficacy of GLP-1 Agonist Medicines: Based on Dr. Spencer Nadolsky, D.O. and Weight problems and Lipid Specialist, these meds do have their limits.
Proper now, the typical is round 20% weight reduction with Tizepatide (Mounjaro). For a 400 pound particular person, that may imply 80 kilos misplaced. That particular person nonetheless has weight problems.
Along with this, Dr. Nadolsky strengthened the truth that not everybody responds to those drugs.
Root Causes of Weight problems: Weight problems is pushed by advanced components, together with socioeconomic disparities, meals system points, and sedentary life. Conversely, GLP-1 drugs primarily goal processes equivalent to urge for food regulation and insulin sensitivity. These are clearly necessary, however to actually impact change on weight problems charges, there must be a complete focus not solely on pharmacology, but additionally public well being interventions. A 2023 overview in Nature Medication proposed that initiatives to handle this difficulty which have 4 components: informing the general public about diet, enabling them to make health-promoting selections, motivating them to make adjustments to their routines and habits, and influencing behaviour through social norms and different strategies.
The overview steered rising lively transport, rising healthcare payor incentives, bettering entry to and affordability of wholesome meals, limiting availability and media advertising of high-calorie meals, bettering meals labeling, reformulating meals merchandise to be extra healthful, and rising entry to weight administration applications and bariatric surgical procedure.
Facet Results and Contraindications: Frequent unwanted effects of GLP-1 drugs, equivalent to nausea, vomiting, and gastrointestinal discomfort, can deter adherence. Moreover, these medication are contraindicated for people with sure circumstances, equivalent to kidney illness, sure cancers, and a historical past of pancreatitis.
The Position of Dietary Interventions
GLP-1 drugs are efficient for most individuals, however adjustments in weight loss program do should be a part of their use. Dietary methods can improve the efficacy of remedy whereas supporting long-term well being.
Listed here are some suggestions for consuming whereas on a GLP-1 drugs:
Prioritize Protein and Fiber: GLP-1 drugs gradual gastric emptying, selling early satiety. Which means that most meals and snacks must be nutrient-dense to keep away from nutrient deficiencies and promote general well being. A weight loss program wealthy in lean proteins (e.g., meat and fish, tofu, eggs, Greek yogurt and ricotta, beans and lentils) helps to keep up muscle mass. Getting ~25+ grams of fiber per day from greens, complete grains, and fruits, helps maintain fullness and helps blood sugar management. Don’t sleep on beans or soy meals as a technique to get high-quality protein and fibre in a single place!
Reduce Extremely-Processed Meals: Processed meals excessive in refined carbohydrates, added sugars, and unhealthy fat can counteract the advantages of GLP-1 drugs. I like to recommend specializing in complete, minimally processed meals to enhance general metabolic well being. That additionally means minimizing alcohol and different lower-quality meals to assist maximize vitamins in your weight loss program.
Hydration and Small, Frequent Meals: Folks on GLP-1 drugs usually expertise nausea, which could be mitigated by staying hydrated and consuming smaller, extra frequent meals. On nauseous days, incorporating meals which are light on the abdomen, equivalent to soups and smoothies, may also help.
Aware Consuming Practices: GLP-1 drugs cut back urge for food, creating a chance to apply aware consuming. Slowing down throughout meals, savoring meals, and listening to starvation cues may also help reinforce wholesome consuming behaviors.
Rising Weight Loss Medicines
Along with current GLP-1 receptor agonists, a number of promising weight reduction drugs are below growth or awaiting approval:
- Orforglipron Eli Lilly is creating Orforglipron, an oral GLP-1 receptor agonist. This remedy might present an alternate for sufferers preferring to not use injectables.
- CagriSema (Cagrilintide/Semaglutide Mixture) Novo Nordisk is advancing this mixture remedy, exhibiting important weight reduction results in early trials.
- Retatrutide Retatrutide is a triple-hormone receptor agonist, with early research reporting substantial weight discount.
- VK2735 Viking Therapeutics is exploring VK2735, an oral remedy with promising preliminary outcomes.
Conclusion
GLP-1 drugs supply important advantages for people combating weight problems, however they don’t seem to be a panacea for the broader epidemics. Addressing these advanced, multifactorial challenges requires a complete strategy that mixes medical innovation with sturdy public well being efforts. By integrating dietary methods, selling equitable entry to care, and tackling systemic points, we will make significant progress towards reversing the developments in weight problems.
Are you searching for assist along with your diet? I’m taking new purchasers in my 1:1 apply. Get extra info and ebook a session right here.
Do you know? I even have a web based course for diet in perimenopause and menopause known as Don’t Sweat It. Get extra info and enroll right here.
